Randomised controlled trial to evaluate tolerance of a new fibre-enriched sip feed in subjects in need of oral nutritional support.

1. Subjects (male/female) ≥ 50 years of age at the start of the Baseline period;

2. Subject is prescribed oral nutritional support of  300 kcal/day of sip feed (subject can be current or new user);

3. In case of new users: MUST score 1 (medium risk of malnutrition), or 2 or more (high risk of malnutrition);

4. Subject is expected to require oral nutritional support for at least 4 weeks;

5. Subject has given written informed consent;

6. Subject is able to comply with the protocol (e.g. answer questions).

1. Known inflammatory bowel diseases (e.g. Crohn’s disease);

2. Known lactose intolerance and not using lactase;

3. Known galactosemia;

4. Known cow’s milk allergy;

5. Known major hepatic dysfunction: symptomatic hepatic dysfunction or previous serum transaminase (ALAT, ASAT, or alkaline phosphatase) levels more than 5 times upper limit of normal;

6. Known major renal dysfunction: symptomatic renal dysfunction, previous serum creatinine level more than 1.8 times upper limit of normal, or requiring dialysis;

7. Subject with an ileostomy or colostomy;

8. Parenteral feeding;

9. Tube feeding;

10. Investigator's uncertainty about the willingness or ability of the subject to comply with the protocol requirements;

11. Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study.